Norwegian Core Facility for Human Pluripotent Stem Cells (Oslo University Hospital)
Oslo, Norway ous-research.no
From their website, Nov 2026
Work here? Claim this listing
About
The Norwegian Core Facility for Human Pluripotent Stem Cells at Oslo University Hospital provides production, characterization, differentiation, banking, and gene editing services for human embryonic stem cells and induced pluripotent stem cells. It supports researchers working on stem cell derivation, disease modeling, and pre-GMP protocol development, and is located at Domus Medica in Oslo, Norway.
Services
Reprogramming of hiPS cells from skin biopsies and blood samples
Derives induced pluripotent stem cell lines from skin biopsy or blood donor material.
Characterization of hES and hiPS cells
Assesses pluripotency markers and embryoid body formation in human ES and iPS cells.
Training and assistance in cultivation of hES and hiPS cells
Provides instruction and hands-on support for culturing human ES and iPS cells.
Long-term storage of skin fibroblasts and hiPS cells
Stores skin fibroblasts and hiPS cells for long-term use.
Mycoplasma testing
Tests cell cultures for mycoplasma contamination.
STR analysis
Performs STR analysis for cell line authentication.
Use of laboratory space
Provides access to a quarantine lab, a BS2-classified virus lab, and a variable oxygen cell cultivation unit.
Differentiation of selected cell types from hES and hiPS cells
Differentiates human ES and iPS cells into selected cell types.
Strategic planning of reprogramming experiments and in vitro disease modeling
Advises on experimental design for reprogramming and disease-modeling studies.
Cell characterization equipment access
Provides access to qPCR, flow cytometry, and a user-available confocal microscope for cell characterization.
CRISPR gene editing services
Carries out CRISPR-based genome editing in human iPSCs.
Knock-in generation
Creates knock-in edits in human iPSCs.
Knock-out editing
Creates knockout edits in human iPSCs.
SNP correction
Performs single-nucleotide polymorphism correction in human iPSCs.
Reporter iPSC generation
Generates reporter iPSC lines.
Pluripotency testing of user-provided cells
Tests user-provided cells by qPCR, immunocytochemistry, and confocal microscopy.
Differentiation via EB to three germ layers
Differentiates cells through embryoid bodies to assess three germ layer potential.
Genetic karyotyping of hES and hiPSCs
Performs karyotyping on human ES and iPS cells.
Differentiation via hiPSCs to human neural progenitor cells
Differentiates hiPSCs into human neural progenitor cells.
Flow cytometry and DNA analysis
Provides flow cytometry and DNA analysis services for samples.
- Turnaround
- Mycoplasma testing requests for weekend needs must be submitted by 12:00 Thursday
- What to send
- Skin biopsies · Blood samples · Pluripotent cell lines · Cells to be analysed with antibody details · Vector and nucleic acid insert for virus lab requests · Cells intended for mycoplasma testing must be cultivated in quarantine area or a Core Facility-approved incubator for 24
- Minimums and prices
- Training in hiPSC cultivation: 6000 NOK /person or 9000 NOK /two people · Use of confocal microscope: 100 NOK /hour · Quarantine cell culturing prior to mycoplasma testing: 100 NOK /day · Human Feeders (irradiated): 20 NOK /35 mm dish · hiPSC generation: 1000 NOK /line (2 cryotubes/biopsy) · hiPSC generation: 35 000 NOK /donor (4-5 iPSC lines/donor) · Gene Editing (CRISPR) Knock Out editing: 60 000 NOK /line · Gene Editing (CRISPR) Knock-in generation: 70 000 NOK /line · Gene Editing (CRISPR) Point mutation (SNP) correction/insertion: 70 000 NOK /line · Gene Editing (CRISPR) Reporter cell line generation: 70-75 000 NOK /line · Media/reagents hESC medium: 1000 NOK /500 mL · Mycoplasma detection in cell culture media: 300 NOK /test
3 more
Storage (liquid nitrogen) of hESC and hiPSCs: 1000 NOK /year · Pluripotency testing: 400 NOK /plate · Pluripotency testing: 1000 NOK /line
Capabilities
- Assays and studies
- Pluripotency marker expression · Embryoid body formation · Mycoplasma testing · STR analysis · qPCR · Flow cytometry · Confocal microscopy · Immunocytochemistry · Karyotyping · DNA analysis · Sanger sequencing · RFLP-based confirmation
2 more
ICE analysis · TIDE analysis - Scale and capacity
- 140 m2 lab space · 4 fully equipped cell culture rooms · At least five vials of two edited clones · 0.5 million cells per vial
- Therapeutic areas
- Neurological disease · Endocrine disease · Ocular disease · Cell-based therapies
Instruments and platforms
- qPCR
- Flow cytometry
- Confocal microscope
- Neon Electroporation system
- Amaxa
- IOTA single cell dispenser
- Isohub system
Modalities and species
- Modalities
- Gene editing
- Species and models
- Human ES cells · Human iPS cells · Skin fibroblasts · Skin biopsies · Blood samples · Human neural progenitor cells
Certifications
As the company states them, with the certificate or registry record where there is one.
GMPSelf-reported
Scope: donor cell collection, isolation and preparation for reprogramming
Company
- Type
- Core facility
- Founded
- 2009
- Team
- 10 research groups
- Quality
- REK-approved projects · BS2-classified virus lab · pre-GMP (iPS cell reprogramming and differentiation protocols) · GMP-compliant protocols (donor cell collection, isolation and preparation for reprogramming)
Locations
- Based in
- Oslo, Norway
- Sites
- Oslo, Norway · Akershus University Hospital, Norway
- Serves
- Norway
Public records
- Research Resource Identifier (CoreMarketplace)
- RRID:SCR_023247 source
Similar labs
Work here? Claim this listing